2010 Annual Meeting

Session: Model Based QbD in Drug Substance or Drug Product

This session invites presentations in which response models have been developed from measured data for operations in drug substance or drug product development. These models may result from statistical design of experiments, a mechanistic / first principles approach, or a combination of the two. Submissions that address model verification are particularly welcome, for example using separate model development and model verification data sets.

Chair

Richard Schild, Bristol-Myers Squibb

Co-Chair

Nandkishor K. Nere, Abbott Laboratories

Presentations

03:15 PM

Rahul Bharadwaj, Pankaj Doshi, Mary T. Am Ende, Salvador Garcia-Munoz, William R. Ketterhagen, Andrew Prpich

03:35 PM

03:55 PM

Stephen A. Guzikowski, James S. Bergum, Michael P. Cassidy, Chiajen J. Lai, Sunil S. Patel, Michael E. Randazzo, Thomas M. Razler, Emily A. Reiff, Victor W. Rosso, Jose Tabora, John E. Thornton, Xuejun Xu, Dong Lin

04:15 PM

Patrick J. Whitcomb, Mark J. Anderson

04:45 PM

05:05 PM

Maria Elisa Luque, Bo Zhou, Rodolfo Pinal, Gintaras V. Reklaitis, Venkat Venkatasubramanian

05:25 PM

Eric Lueshen, Cierra Hall, Andrej Mošat, Andreas A. Linninger